Clinical Trial Update: Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating mobilization and collection of peripheral hematopoietic stem cells using Plerixafor plus G-CSF in Japanese patients with Non-Hodgkin ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Filgrastim (filgrastim)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Lymphoma | Phase 2 | Status: COMPLETED